This comprehensive resource looks at PARP inhibition and DDR as therapeutic targets across multiple tumour types
We celebrate our 10-year anniversary at the COR2ED booth during ESMO 2022. In 10 years, 500,000 healthcare professionals have trusted our educational programmes.
COR2ED presents an update on selected General Sessions from SABCS 2022
The physicians' perspective
Episode 1: Non-Small-Cell Lung Cancer Update: ADAURA trial
Episode 1: Overview of Clinical Data of SERDs & Their Place in Treatment Landscape
An interactive patient case video series from breast cancer specialists
Follow a patient's breast cancer journey from diagnosis to treatment options
An interactive patient case video series from breast cancer specialists
Explore a patient case from testing, diagnosis and treatment